MedPath

The Impact of Chloroprocaine 3% for Ambulatory Foot Surgery on Perioperative Process Costs

Completed
Conditions
Impact of Anesthetic Choice on Costs
Interventions
Registration Number
NCT02406703
Lead Sponsor
Ospedale Regionale Bellinzona e Valli
Brief Summary

Background and Objectives Short acting regional anesthetics have already been successfully employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on direct and indirect perioperative costs comparing two different short-acting local anesthetics has not been performed, yet.

Methods In an observational study including 50 patients per group, patient undergoing popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery were compared. The primary outcome was the saving of both direct and indirect perioperative costs. Secondary outcomes were block success, onset time and block duration, patient satisfaction and unplanned outpatient visits or readmissions after discharge.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery (percutaneous hallux valgus correction, osteotomies, tenotomies, mallet and hammer toes correction, screws and/or plaques removal)
Exclusion Criteria
  • known allergy to drugs used in the study;
  • coagulopathies, known neuropathy;
  • pregnancy;
  • chronic pain;
  • drug or alcohol abuse;
  • psychiatric disease or lack of competence affecting compliance and evidence of ongoing sepsis or local skin / subcutaneous tissues infections in the popliteal fossa.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ChloroprocaineChloroprocainePatient undergoing popliteal block with chloroprocaine
MepivacaineMepivacainePatient undergoing popliteal block with mepivacaine
Primary Outcome Measures
NameTimeMethod
Cost minimization analysis6 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath